Cabio Biotech (Wuhan) Co., Ltd.

SHSE:688089 Rapporto sulle azioni

Cap. di mercato: CN¥3.5b

Cabio Biotech (Wuhan) Gestione

Gestione criteri di controllo 3/4

Cabio Biotech (Wuhan) Il CEO è Dewei Yi, nominato in Dec2015, ha un mandato di 8.92 anni. possiede direttamente 1.39% delle azioni della società, per un valore di CN¥ 48.35M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 8.9 anni e 5.9 anni.

Informazioni chiave

Dewei Yi

Amministratore delegato

CN¥1.1m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO8.9yrs
Proprietà del CEO1.4%
Durata media del management8.9yrs
Durata media del Consiglio di amministrazione5.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Think That There Are Issues Underlying Cabio Biotech (Wuhan)'s (SHSE:688089) Earnings

Nov 04
We Think That There Are Issues Underlying Cabio Biotech (Wuhan)'s (SHSE:688089) Earnings

Cabio Biotech (Wuhan) (SHSE:688089) Might Be Having Difficulty Using Its Capital Effectively

Oct 28
Cabio Biotech (Wuhan) (SHSE:688089) Might Be Having Difficulty Using Its Capital Effectively

Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

Oct 01
Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Aug 06
There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Jun 07
Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

May 06
Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

May 03
Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

Mar 21
The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

AMMINISTRATORE DELEGATO

Dewei Yi (59 yo)

8.9yrs

Mandato

CN¥1,090,600

Compensazione

Mr. Dewei Yi is Chairman and General Manager of CABIO Biotech(Wuhan) Co., Ltd., since December 2015. From December 1999 he has been the chairman of Wuhan Xiwang Biological Engineering Co., Ltd.; since Nove...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Dewei Yi
Chairman & GM8.9yrsCN¥1.09m1.39%
CN¥ 48.4m
Huabiao Wang
Financial Director & Director8.9yrsCN¥781.40k0.66%
CN¥ 23.0m
Huarong Yi
Deputy GM & Secretary of the Board of Directorsno dataCN¥640.10k0.089%
CN¥ 3.1m
Anfeng Geng
Deputy General Manager3.7yrsCN¥713.40k0.098%
CN¥ 3.4m
Zhiming Wang
Deputy General Manager2.9yrsCN¥862.90k0.14%
CN¥ 5.0m
Xiangyu Li
Deputy General Manager8.9yrsCN¥763.90k0.12%
CN¥ 4.2m
Tao Ma
Deputy General Manager8.9yrsCN¥640.90k0.093%
CN¥ 3.3m
Hao Xiong
Accounting Supervisorno dataNessun datoNessun dato

8.9yrs

Durata media

48yo

Età media

Gestione esperta: Il team dirigenziale di 688089 è esperto e expertise (durata media dell'incarico 8.9 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Dewei Yi
Chairman & GM8.9yrsCN¥1.09m1.39%
CN¥ 48.4m
Huabiao Wang
Financial Director & Director8.9yrsCN¥781.40k0.66%
CN¥ 23.0m
Bin Du
Vice Chairman8.9yrsCN¥984.80k0.58%
CN¥ 20.3m
Yujun Wu
Employee Representative Supervisor8.9yrsNessun dato0.018%
CN¥ 634.3k
Chunyu Zhang
Director2.9yrsNessun datoNessun dato
Xiangdong Chen
Independent Director2.9yrsCN¥80.00kNessun dato
Qi Liu
Independent Director2.9yrsCN¥80.00kNessun dato
Jing Chen
Supervisor2.9yrsNessun datoNessun dato

5.9yrs

Durata media

53.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 688089 sono considerati esperti (durata media dell'incarico 5.9 anni).